by BGI GenomicsClinical information of the collected samples. (A) The age distribution of the normal group and GDM group. (B) The weight distribution of the normal group and GDM group. (C) The sample
by BGI GenomicsClinical information of the collected samples. (A) The age distribution of the normal group and GDM group. (B) The weight distribution of the normal group and GDM group. (C) The sample
byUniversity of CopenhagenCredit: Unsplash/CC0 Public DomainSince 2010, the number of people with obesity in Denmark has doubled, while other countries have seen an even greater increase. But wh
byUniversity of CopenhagenCredit: Unsplash/CC0 Public DomainSince 2010, the number of people with obesity in Denmark has doubled, while other countries have seen an even greater increase. But wh
by Deborah Lancastle,The ConversationCredit: AI-generated imageMenopause can cause more symptoms than hot flushes alone. And some of your symptoms and reactions might be due to the menopause, ev
by Deborah Lancastle,The ConversationCredit: AI-generated imageMenopause can cause more symptoms than hot flushes alone. And some of your symptoms and reactions might be due to the menopause, ev
by DeeDee Stiepan, Mayo Clinic News NetworkCredit: CC0 Public DomainOne of the most common New Year's resolutions is to lose weight. Many may be wondering if weight-loss medications can help them
by DeeDee Stiepan, Mayo Clinic News NetworkCredit: CC0 Public DomainOne of the most common New Year's resolutions is to lose weight. Many may be wondering if weight-loss medications can help them
by Université catholique de LouvainResearchers from University of Louvain (UCLouvain) have discovered a new bacterium in the human intestine, they called Dysosmobacter welbionis. The UCLouvain sc
by Université catholique de LouvainResearchers from University of Louvain (UCLouvain) have discovered a new bacterium in the human intestine, they called Dysosmobacter welbionis. The UCLouvain sc
Clinical studies have demonstrated that both tirzepatide and semaglutide are effective in promoting weight loss among individuals with overweight or obesity.
Clinical studies have demonstrated that both tirzepatide and semaglutide are effective in promoting weight loss among individuals with overweight or obesity.
by University of BirminghamCredit: Unsplash/CC0 Public DomainDoctors are feeling unable to tackle the growing problem of childhood obesity due to a lack of training and capacity according to new
by University of BirminghamCredit: Unsplash/CC0 Public DomainDoctors are feeling unable to tackle the growing problem of childhood obesity due to a lack of training and capacity according to new
by Robin FosterZepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly."Given the increased interest a
by Robin FosterZepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly."Given the increased interest a
byBritish Medical JournalCredit: Pixabay/CC0 Public DomainThe diabetes drug dulaglutide (Trulicity) may significantly lower a woman's risk of substantial weight gain after she has given up s
byBritish Medical JournalCredit: Pixabay/CC0 Public DomainThe diabetes drug dulaglutide (Trulicity) may significantly lower a woman's risk of substantial weight gain after she has given up s
by Lois Yoksoulian,University of Illinois at Urbana-ChampaignXiaohui Zhang, left, Andrew Smith, Kelly Swanson, Erik Nelson, Mark Anastasio and Junlong Geng are part of a team working to clarify
by Lois Yoksoulian,University of Illinois at Urbana-ChampaignXiaohui Zhang, left, Andrew Smith, Kelly Swanson, Erik Nelson, Mark Anastasio and Junlong Geng are part of a team working to clarify
by Brigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainFecal incontinence (FI), or involuntary loss of bowel control, significantly impacts quality of life and mental health for millions of a
by Brigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainFecal incontinence (FI), or involuntary loss of bowel control, significantly impacts quality of life and mental health for millions of a